391 related articles for article (PubMed ID: 26255991)
21. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
22. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome.
Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650
[TBL] [Abstract][Full Text] [Related]
23. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
24. A Cross-Sectional Exploratory Study of Cardiovascular Risk Biomarkers in Non-Obese Women with and without Polycystic Ovary Syndrome: Association with Vitamin D.
Nandakumar M; Das P; Sathyapalan T; Butler AE; Atkin SL
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928037
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
[TBL] [Abstract][Full Text] [Related]
26. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome.
Wehr E; Trummer O; Giuliani A; Gruber HJ; Pieber TR; Obermayer-Pietsch B
Eur J Endocrinol; 2011 May; 164(5):741-9. PubMed ID: 21389086
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study.
Krul-Poel YHM; Koenders PP; Steegers-Theunissen RP; Ten Boekel E; Wee MMT; Louwers Y; Lips P; Laven JSE; Simsek S
PLoS One; 2018; 13(12):e0204748. PubMed ID: 30513089
[TBL] [Abstract][Full Text] [Related]
29. Vitamin D status and risk of metabolic syndrome among non-diabetic young adults.
Huang CY; Chang HH; Lu CW; Tseng FY; Lee LT; Huang KC
Clin Nutr; 2015 Jun; 34(3):484-9. PubMed ID: 24953770
[TBL] [Abstract][Full Text] [Related]
30. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
Sam S; Scoccia B; Yalamanchi S; Mazzone T
Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
[TBL] [Abstract][Full Text] [Related]
31. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
[TBL] [Abstract][Full Text] [Related]
32. Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome.
Livadas S; Kollias A; Panidis D; Diamanti-Kandarakis E
Eur J Endocrinol; 2014 Sep; 171(3):301-9. PubMed ID: 25053727
[TBL] [Abstract][Full Text] [Related]
33. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome.
Lauria PB; Del Puerto HL; Reis AM; Candido AL; Reis FM
J Clin Endocrinol Metab; 2013 Dec; 98(12):4882-9. PubMed ID: 24057296
[TBL] [Abstract][Full Text] [Related]
34. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
35. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
[TBL] [Abstract][Full Text] [Related]
37. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
[TBL] [Abstract][Full Text] [Related]
38. 25(OH) vitamin D levels in premenopausal women with polycystic ovary syndrome and/or obesity.
Tsakova AD; Gateva AT; Kamenov ZA
Int J Vitam Nutr Res; 2012 Dec; 82(6):399-404. PubMed ID: 23823925
[TBL] [Abstract][Full Text] [Related]
39. Serum irisin and its regulation by hyperinsulinemia in women with polycystic ovary syndrome.
Adamska A; Karczewska-Kupczewska M; Lebkowska A; Milewski R; Górska M; Otziomek E; Nikolajuk A; Wolczynski S; Kowalska I
Endocr J; 2016 Dec; 63(12):1107-1112. PubMed ID: 27616010
[TBL] [Abstract][Full Text] [Related]
40. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]